Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks
about
Bipolar disorder and mechanisms of action of mood stabilizersLithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascadeChronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortexDietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortexSelective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourSynapsin II is involved in the molecular pathway of lithium treatment in bipolar disorderMode of action of mood stabilizers: is the arachidonic acid cascade a common target?Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patientsChronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorderTranscriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation.Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.Neuroprotective effects of psychotropic drugs in Huntington's diseaseChronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats.Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat.Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism.Anticonvulsants in bipolar disorder
P2860
Q22252332-3790A7D0-7A25-4BE8-956A-9BADF73D08B3Q26850084-0A28CE9C-A114-423C-ACAD-8AC07918CE43Q28577930-00EC4444-0DCE-45FF-8570-D6E7D9121E7AQ28581107-57D07B1B-9F6E-4B2E-9918-A699422DC026Q30522548-8016D99B-8E91-4FFC-B656-B4E4F091A4B6Q34182827-722033E5-70ED-4B13-9C81-BC2B4C599CD3Q34762525-58741BDB-2096-48E6-B23E-9ED84C727A23Q35306297-B6AE8102-8753-4B4B-8F38-4D39BABF39D7Q35308508-3AD59A64-DF3F-493D-8831-A5DC74F54B1AQ35476477-90EE1AFF-3E90-46F0-AF2E-63A3F9AEA043Q35604900-60FBB155-6C0E-4096-8E03-8E98B0212583Q35742545-A1276D58-33DE-4802-84A4-49CF5A73952EQ36338186-D4E0CE2D-7BE4-4C26-A35C-66A389F526ACQ36953315-0F29404A-20F8-40DB-B374-CA1084B204A9Q37088689-0CF4E36C-C948-4FF8-ABE1-C65437E59B43Q37335559-325E4785-D7BC-41C0-8E5F-9C470CF7A2D2Q37590122-B9B0A9D4-D9E7-40A5-8DA2-9E5FBCB6C424Q38163877-56D58058-9377-4631-9D73-7A8EE4E52972Q46808102-44522F0C-05CC-406F-8003-FA4B37CEBE54Q46934944-B757ACBD-7C02-49BB-93F7-DC115B582862Q48146045-25867C6C-0D56-45C4-B1C7-A5F158436340Q48375218-6C839435-EDFE-4ADD-AF2E-7B9A3303188DQ48418353-4F446BF5-0025-4F25-9816-8A3FCBD97233Q56637792-227D5B2F-365A-4900-85B0-BBDAD6C9617E
P2860
Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks
description
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im November 2005 veröffentlichter wissenschaftlicher Artikel
@de
retracted scientific journal article
@en
vedecký článok (publikovaný 2005/11/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/11/01)
@nl
наукова стаття, опублікована в листопаді 2005
@uk
مقالة علمية (نشرت في نوفمبر 2005)
@ar
name
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@ast
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@en
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@nl
type
label
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@ast
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@en
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@nl
prefLabel
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@ast
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@en
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@nl
P2860
P356
P1476
Decrease in the AP-2 DNA-bindi ...... eated with lithium for 6 weeks
@en
P2093
Francesca Bosetti
Jagadeesh S. Rao
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300740
P407
P577
2005-11-01T00:00:00Z
P5875
P6179
1016594716